Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07631104
What this trial is testing

Improving the HIV Care Continuum With mHealth Technology

Who this might be right for
HIV - Human Immunodeficiency VirusHIV Antiretroviral Therapy (ART) AdherencemHealth Application+3 more
University of South Carolina 40
Not applicableUnknownNCT02586584
What this trial is testing

The I-Score Study: Developing a New Patient-Reported Tool for the Routine HIV Care of Patients on Antiretroviral Therapy

Who this might be right for
HIV/AIDS
Dr. Bertrand Lebouche 160
Post-approval studies (Phase 4)Study completedNCT03630549
What this trial is testing

Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in Lesotho

Who this might be right for
HIV/AIDS
Niklaus Labhardt 257
Not applicableStudy completedNCT01253850
What this trial is testing

Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I

Who this might be right for
HIV Infection
Fenway Community Health 31
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Post-approval studies (Phase 4)Study completedNCT00869960
What this trial is testing

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women

Who this might be right for
Healthy
University of Alabama at Birmingham 24
Not applicableStudy completedNCT00050908
What this trial is testing

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableStudy completedNCT03799276
What this trial is testing

Optimisation of Care in Vulnerable HIV Infected Individuals

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 200
Not applicableStudy completedNCT06107140
What this trial is testing

Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort

Who this might be right for
HIV Infections
Tourcoing Hospital 580
Testing effectiveness (Phase 2)Looking for participantsNCT07336797
What this trial is testing

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Who this might be right for
Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud 66
Testing effectiveness (Phase 2)Study completedNCT01968850
What this trial is testing

Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial

Who this might be right for
HIV
Unity Health Toronto 30
Not applicableStudy completedNCT00001117
What this trial is testing

Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Ended earlyNCT01338025
What this trial is testing

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

Who this might be right for
HIV Disease
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 33
Large-scale testing (Phase 3)UnknownNCT05735535
What this trial is testing

Women in Dual With Dolutegravir

Who this might be right for
HIV Infections
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Testing effectiveness (Phase 2)Study completedNCT03272347
What this trial is testing

Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 123
Testing effectiveness (Phase 2)Study completedNCT00617526
What this trial is testing

Naïve HIV POC Monotherapy Trial

Who this might be right for
HIV Infections
Ardea Biosciences, Inc. 48
Post-approval studies (Phase 4)Study completedNCT00232908
What this trial is testing

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 361
Not applicableStudy completedNCT04115813
What this trial is testing

Project YES! Youth Engaging for Success

Who this might be right for
HIV/AIDS
Johns Hopkins Bloomberg School of Public Health 276
Not applicableLooking for participantsNCT04149782
What this trial is testing

Gathering Records to Evaluate Antiretroviral Treatment-South Africa

Who this might be right for
HIV
Boston University 7,000,000
Not applicableStudy completedNCT01190124
What this trial is testing

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Who this might be right for
HIV Infections
Doroana, Maria Manuela, M.D. 151
Next Page